Pharmacological Approaches in Cancer Treatment

Delving into Cancer Pharmacology: A Comprehensive Guide presents an in-depth exploration of pharmacological approaches utilized in cancer treatment. Its overarching theme revolves around understanding the intricate mechanisms and applications of various therapies, ranging from targeted treatments to immunotherapies. Through examination and analysis, the book sheds light on emerging trends and breakthroughs in the field, providing a comprehensive overview of cancer pharmacology. Across its ten chapters, the book covers a wide array of topics, offering insights into targeted therapies, chemotherapy agents, immunotherapy, personalized medicine, combination therapies, drug resistance, novel drug delivery systems, palliative care in oncology, adverse effects of cancer pharmacotherapy, and preclinical studies. Each chapter provides the nuances of its respective subject matter, providing readers with a thorough understanding of the scientific underpinnings and practical applications of cancer pharmacology. Designed to cater to both oncology professionals and patients, Delving into Cancer Pharmacology serves as a valuable resource for enhancing understanding and informing treatment decisions. By synthesising cutting-edge research with practical clinical insights, the book equips readers with the knowledge and tools necessary to navigate the complexities of cancer pharmacology. Whether seeking to stay abreast of the latest advancements or seeking guidance on treatment options, readers will find this book to be an indispensable companion in the fight against cancer.

• Connects pharmacological and theoretical aspects with practical ones based on real world analysis
• Focuses on the pharmacological approaches, personalised medicine as well as case studies and real-world examples
• Gives a clear division into target therapies and chemotherapy with their applications bringing order to cancer treatment
• Provides guidance and brings order to the vast therapeutic armamentarium available to physicians in cancer treatment